Development of an Allogeneic Universally Tolerated NKT Cell Platform for Off-the-Shelf Cancer Immunotherapy

被引:0
|
作者
Jin, Jingling [1 ]
Liu, Bin [1 ]
Guo, Linjie [1 ]
Di Pierro, Erica J. [1 ]
Balzeau, Julien [1 ]
Courtney, Amy [1 ]
Ngai, Ho [1 ]
Metelitsa, Leonid S. [1 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
682
引用
收藏
页码:321 / 321
页数:1
相关论文
共 50 条
  • [41] Development of Master Multiplexed-Engineered iPSC Bank for Off-the-Shelf Cell-Based Cancer Immunotherapy with Reduced Conditioning Chemotherapy
    Pan, Yijia
    Jelcic, Mark
    Goodridge, Jode
    Williams, Alan
    Hayama, Ken
    Mbofung, Rina
    Groff, Brian
    Tsai, Pei-Fang
    Lee, Tom T.
    Valamehr, Bahram
    MOLECULAR THERAPY, 2022, 30 (04) : 179 - 179
  • [42] DEVELOPMENT OF AN OFF-THE-SHELF ALLOGENEIC THERAPEUTIC PRODUCT INTENDED FOR BONE REGENERATION WITH IMMUNOSUPPRESSIVE PROPERTIES
    Theys, N.
    Episkopou, H.
    Brenner, C.
    Dufrane, D.
    CYTOTHERAPY, 2022, 24 (05) : S52 - S53
  • [43] Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies
    Heipertz, Erica L.
    Zynda, Evan R.
    Stav-Noraas, Tor Espen
    Hungler, Andrew D.
    Boucher, Shayne E.
    Kaur, Navjot
    Vemuri, Mohan C.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] UCART19, an Allogeneic "Off-the-Shelf" Adoptive T-Cell Immunotherapy Against CD19+B-Cell Leukemias
    Poirot, Laurent
    Philip, Brian
    Schiffer-Mannioui, Cecile
    Derniame, Sophie
    Zhan, Hong
    Stafford, Sian
    Galetto, Roman
    Reynier, Stephan
    Arnould, Sylvain
    Gouble, Agnes
    Qasim, Waseem
    Pule, Martin
    Smith, Julianne
    MOLECULAR THERAPY, 2015, 23 : S286 - S286
  • [45] UCART19, AN ALLOGENEIC "OFF-THE-SHELF" ADOPTIVE T-CELL IMMUNOTHERAPY AGAINST CD19+B-CELL LEUKEMIAS
    Poirot, L.
    Philip, B.
    Mannioui, C. Schiffer
    Derniame, S.
    Zhan, H.
    Stafford, S.
    Reynier, S.
    Arnould, S.
    Gouble, A.
    Qasim, W.
    Peggs, K.
    Pule, M.
    Smith, J.
    HAEMATOLOGICA, 2015, 100 : 172 - 172
  • [46] NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
    Garnet Suck
    Marcus Odendahl
    Paulina Nowakowska
    Christian Seidl
    Winfried S. Wels
    Hans G. Klingemann
    Torsten Tonn
    Cancer Immunology, Immunotherapy, 2016, 65 : 485 - 492
  • [47] NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy
    Suck, Garnet
    Odendahl, Marcus
    Nowakowska, Paulina
    Seidl, Christian
    Wels, Winfried S.
    Klingemann, Hans G.
    Tonn, Torsten
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (04) : 485 - 492
  • [48] Improvement of "off-the-shelf'' allogeneic CAR-T cells
    Pavlovic, K.
    Carmona, M. D.
    Maldonado, N.
    Tristan, M.
    Cortijo, M.
    Nogueras, S.
    Jimenez, R.
    Martin, F.
    Herrera, I. C.
    Benabdellah, K.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A87 - A87
  • [49] The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
    Fabian, Kellsye P.
    Hodge, James W.
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 23 : 266 - 276
  • [50] Allogeneic "Off-the-Shelf" CAR T cells: Challenges and advances
    Chen, Sophia
    van den Brink, Marcel R. M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2024, 37 (03)